Conservative Site-specific Recombination and Phase Variation
Chromatin Immunoprecipitation- ChIP
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 26, 2025

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
Published on: January 12, 2024
Anja Vogelmann1, Dina Robaa2, Wolfgang Sippl2
1Institute of Pharmaceutical Sciences, University of Freiburg, Albertstraße 25, Freiburg, 79104, Germany.
Proteolysis targeting chimeras (PROTACs) offer a novel method for targeted protein degradation. This review highlights recent advancements in PROTACs, particularly for epigenetic targets in drug discovery.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: